Grants per year
Grants 1999 2024
- 1 - 25 out of 30 results
- Status, start date (descending)
Active
Prot:ALXN1210-MG-306: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis
INC Research, LLC, Alexion Pharmaceuticals, Inc.
1/17/20 → 1/17/23
Project: Research project
Natural History
Databases
Motor Neuron Disease
Standard of Care
Clinical Trials
Master Clinical Trial Agreement - HEALEY ALS Platform Trial
Massachusetts General Hospital
12/5/19 → 12/4/24
Project: Research project
Amyotrophic Lateral Sclerosis
Clinical Trials
Informed Consent
General Hospitals
Budgets
ODM-109:Effects of Oral Levosimendan(ODM-109) on Respiratory Function in Patients with ALS:
PRA Health Sciences, Orion Group
5/31/18 → 5/31/21
Project: Research project
Consortium Member and Peripheral Neuropathy Research Registry Agreement
Foundation for Peripheral Neuropathy
1/1/18 → 12/31/20
Project: Research project
Peripheral Nervous System Diseases
Registries
Research
Neuralgia
Neurologic Examination
Answer ALS: Individualized Initiative for ALS Discovery
Johns Hopkins University, Les Turner Amyotrophic Lateral Sclerosis Foundation, Ltd.
1/1/18 → 12/31/20
Project: Research project
Amyotrophic Lateral Sclerosis
Biomarkers
Research Personnel
Pharmaceutical Preparations
Research
Prot #ALN-TTR02-006: A Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of Patisiran in Patients with Familial Amyloidotic Polyneuropathy who have Completed a Prior Clinical Study with Patisiran
Medpace, Inc., Alnylam Pharmaceuticals, Inc.
2/18/16 → 2/18/22
Project: Research project
Finished
NN103: A Phase II Trial of Rituximab In Myasthenia Gravis
Massachusetts General Hospital , National Institute of Neurological Disorders and Stroke
10/1/14 → 7/31/17
Project: Research project
Myasthenia Gravis
Prednisone
Informed Consent
Steroids
Placebos
ALN-TTR02-004 – “APOLLO: A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ALN-TTR02 in Transthyretin (TTR)-Mediated Polyneuropathy (Familial Amyloidotic Polyneuropathy-FAP)”
Medpace, Inc., Alnylam Pharmaceuticals, Inc.
4/17/14 → 1/31/18
Project: Research project
International GBS Outcome Study (IGOS)
GBS/CIDP Foundation International, Inc.
3/1/13 → 2/28/18
Project: Research project
Outcome Assessment (Health Care)
Study no. IgPro20-3003: Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Study to Investigate the Efficacy, Safety, and Tolerability of 2 Different Doses of IgPro20 (Subcutaneous Immunoglobulin) for the Treatment of Chro
ICON Clinical Research, LLC, CSL Behring
12/11/12 → 12/11/15
Project: Research project
HDE Post-Approval Study (PAS) of NeuRx DPS™ for ALS
Ajroud-Driss, S., Hungness, E., Sufit, R. L. & Wolfe, L. F.
10/4/12 → 10/4/18
Project: Research project
Consortium Member and Peripheral Neuropathy Research Registry Agreement
Foundation for Peripheral Neuropathy
6/1/12 → 12/31/17
Project: Research project
Safety and Efficacy of SOD1 Inhibition by Pyrimethamine in Familial ALS
Hospital for Special Surgery - New York, Muscular Dystrophy Association
6/1/12 → 12/31/14
Project: Research project
Consortium Member and Peripheral Neuropathy Research Registry Agreement
Foundation for Peripheral Neuropathy
10/1/10 → 12/31/13
Project: Research project